It is a case of rinse and repeat here.
NOR , imo, always seem to be able to raise via sophs who seem happy to gain by buying at a discount then waiting to offload during a price sensitive announcement soon after for profit. Symbiosis.
Cases in point:
16/11/17 CR
21/11/17 Norwood partners with Visa https://www.asx.com.au/asxpdf/20171121/pdf/43pds7s62291by.pdf
05/04/17 CR
19/04/19 Revenue Stream from Commsys Agreement Commences
https://www.asx.com.au/asxpdf/20170419/pdf/43hllcjmybnbcl.pdf
28/04/17 Norwood Expands Client Relationship with Oceaneering
https://www.asx.com.au/asxpdf/20170428/pdf/43hvd5vhyddf2t.pdf
15/06/16 CR
11/07/16 offer closing date extended
14/07/16 First Corona Cloud and Corona GTS sales achieved
https://www.asx.com.au/asxpdf/20160714/pdf/438kfgz0w9sjlf.pdf
Quick quiz for those playing at home: did any of those price sensitive announcements amount to adding to LT revenue/profitability/viability?
Imo, the only losers in Norwood are:
1. Loyal LT holders
2. Those who bought high during the WP frenzy in late 2015/early 2016
3. Those who continue to average down
4. Those who do not get access to the soph placement offers
5. Those who may fall into each category above.
Add to My Watchlist
What is My Watchlist?
